Stockreport

Invivyd Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Invivyd, Inc.  (IVVD) 
PDF PEMGARDA® (pemivibart) net product revenue of $13.1 million reported for Q3 2025, representing 41% growth year-over-year and 11% growth quarter-over-quarterOctober 2025 [Read more]